Literature DB >> 12090978

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study.

Anna Norhammar1, Ake Tenerz, Göran Nilsson, Anders Hamsten, Suad Efendíc, Lars Rydén, Klas Malmberg.   

Abstract

BACKGROUND: Glycometabolic state at hospital admission is an important risk marker for long-term mortality in patients with acute myocardial infarction, whether or not they have known diabetes mellitus. Our aim was to ascertain the prevalence of impaired glucose metabolism in patients without diagnosed diabetes but with myocardial infarction, and to assess whether such abnormalities can be identified in the early course of a myocardial infarction.
METHODS: We did a prospective study, in which we enrolled 181 consecutive patients admitted to the coronary care units of two hospitals in Sweden with acute myocardial infarction, no diagnosis of diabetes, and a blood glucose concentration of less than 11.1 mmol/L. We recorded glucose concentrations during the hospital stay, and did standardised oral glucose tolerance tests with 75 g of glucose at discharge and again 3 months later.
FINDINGS: The mean age of our cohort was 63.5 years (SD 9) and the mean blood glucose concentration at admission was 6.5 mmol/L (1.4). The mean 2-h postload blood glucose concentration was 9.2 mmol/L (2.9) at hospital discharge, and 9.0 mmol/L (3.0) 3 months later. 58 of 164 (35%, 95% CI 28-43) and 58 of 144 (40%, 32-48) individuals had impaired glucose tolerance at discharge and after 3 months, respectively, and 51 of 164 (31%, 24-38) and 36 of 144 (25%, 18-32) had previously undiagnosed diabetes mellitus. Independent predictors of abnormal glucose tolerance at 3 months were concentrations of HbA(1c) at admission (p=0.024) and fasting blood glucose concentrations on day 4 (p=0.044).
INTERPRETATION: Previously undiagnosed diabetes and impaired glucose tolerance are common in patients with an acute myocardial infarction. These abnormalities can be detected early in the postinfarction period. Our results suggest that fasting and postchallenge hyperglycaemia in the early phase of an acute myocardial infarction could be used as early markers of high-risk individuals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12090978     DOI: 10.1016/S0140-6736(02)09089-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  205 in total

1.  Oral glucose tolerance test in patients with undiagnosed diabetes and coronary artery disease: when should it be performed?

Authors:  A Kollias; E Diamanti-Kandarakis
Journal:  Diabetologia       Date:  2012-02-04       Impact factor: 10.122

Review 2.  Oxidative stress and diabetic complications.

Authors:  Ferdinando Giacco; Michael Brownlee
Journal:  Circ Res       Date:  2010-10-29       Impact factor: 17.367

3.  JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

Authors: 
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

Review 4.  Prediabetes and cardiovascular risk in hypertensive patients.

Authors:  Julian Segura; Cecilia Roldán; Jose A García-Donaire; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2006-05       Impact factor: 5.369

5.  Impact of pre-diabetic state on clinical outcomes in patients with acute coronary syndrome.

Authors:  R Otten; E Kline-Rogers; D J Meier; R Dumasia; J Fang; N May; Y Resin; D F Armstrong; F Saab; M Petrina; K A Eagle; D Mukherjee
Journal:  Heart       Date:  2005-11       Impact factor: 5.994

6.  [Cardial target-organ damage in diabetes].

Authors:  W Motz; W Kerner
Journal:  Internist (Berl)       Date:  2011-05       Impact factor: 0.743

Review 7.  Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Maria Grazia D'Alfonso; Gian Franco Gensini
Journal:  World J Cardiol       Date:  2014-04-26

8.  Treatment of patients with diabetes with GLP-1 analogues or DPP-4- inhibitors: a hot topic for cardiologists?

Authors:  Thomas Jax
Journal:  Clin Res Cardiol       Date:  2008-10-13       Impact factor: 5.460

9.  [Primary prevention of diabetes mellitus type 2].

Authors:  B Gallwitz
Journal:  Internist (Berl)       Date:  2004-06       Impact factor: 0.743

10.  Random plasma glucose values measured in community dental practices: findings from the Dental Practice-Based Research Network.

Authors:  Andrei Barasch; Gregg H Gilbert; Noel Spurlock; Ellen Funkhouser; Lise-Lotte Persson; Monika M Safford
Journal:  Clin Oral Investig       Date:  2012-08-18       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.